Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMBO Stent in CAD Patients With Indication for Chronic Oral Anticoagulant Therapy
NCT02723981Phase 4Withdrawn
- Sponsor
- Institut für Herzinfarktforschung
- Start
- Apr 2016
- Primary completion
- May 2018
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (2 arms), sponsored by Institut für Herzinfarktforschung. Primary endpoints: Number of patients with bleedings at 6 weeks and Number of patients with safety events at 15 months. Planned start Apr 2016; status: withdrawn.
Beyond the preview
Go deeper on NCT02723981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02723981.